Targeting microbiome, drug metabolism, and drug delivery in oncology
Advanced Drug Delivery Reviews · 2023
DOI: 10.1016/j.addr.2023.114902 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2023. Verfasst von Ai Sumiyoshi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, National Cancer Center Hospital 5-1-1 Tsukiji Chuo, Tokyo 104-0045, Japan. Hauptthemen laut MEDLINE: Microbiota, Gastrointestinal Microbiome, Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 176 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, National Cancer Center Hospital 5-1-1 Tsukiji Chuo, Tokyo 104-0045, Japan.
- Department of Thoracic Oncology, National Cancer Center Hospital 5-1-1 Tsukiji Chuo, Tokyo 104-0045, Japan; Department of Pulmonary Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine,…
- Department of Thoracic Oncology, National Cancer Center Hospital 5-1-1 Tsukiji Chuo, Tokyo 104-0045, Japan. Electronic address: yokuma@ncc.go.jp.
Zitieren
APA
Sumiyoshi, A., Fujii, H., & Okuma, Y. (2023). Targeting microbiome, drug metabolism, and drug delivery in oncology. Advanced Drug Delivery Reviews. https://doi.org/10.1016/j.addr.2023.114902
Vancouver
Sumiyoshi A, Fujii H, Okuma Y. Targeting microbiome, drug metabolism, and drug delivery in oncology. Advanced Drug Delivery Reviews. 2023. doi:10.1016/j.addr.2023.114902
BibTeX
@article{Sumiyoshi2023,
author = {Sumiyoshi, Ai and Fujii, Hiroyuki and Okuma, Yusuke},
title = {Targeting microbiome, drug metabolism, and drug delivery in oncology},
journal = {Advanced Drug Delivery Reviews},
year = {2023},
doi = {10.1016/j.addr.2023.114902}
}
EUVIMED